BioLife Solutions BLFS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| EBITDA margin | -14.8%— | -15.9%— | -15.9%— | —— | —— | |
| Returns | ||||||
| Return on invested capital | -4.9%— | -5.4%— | -5%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.3×— | 0.2×— | 0.2×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 7.3×+2.6× | 5.9×+1.4× | 4.7×+1.9× | 4.4×+1.6× | 4.7×+1.8× | |
| Quick ratio | 5.5×+1.8× | 4.6×+1.0× | 3.6×+1.9× | 3.5×+1.6× | 3.7×+2.0× | |
| Cash ratio | 1.3×-1.2× | 1.4×-1.5× | 1.1×+0.3× | 1.1×+0.4× | 2.4×+1.6× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -5.4×— | -6.4×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $7.56+3.7% | $7.64+0.9% | $7.26+3.0% | $7.26+3.9% | $7.29-0.7% | |
| Valuation | ||||||
| Market capitalization | $1.25B+33.1% | $1.16B-3.3% | $1.22B+5.8% | $1.04B+5.0% | $1.07B+27.5% | |
| Enterprise value | $1.24B+38.1% | $1.15B+0.9% | $1.21B+3.7% | $1.03B+2.8% | $1.03B+21.1% | |
| Price / sales | 12.5×+0.5× | 12.3×— | 13.5×— | —— | —— | |
| Price / book | 3.6×+0.7× | 3.1×-0.3× | 3.5×-0.1× | 3×-0.1× | 3×+0.5× | |
| EV / sales | 13.4×+1.0× | 12.2×— | 13.4×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioLife Solutions's profit margins?
- BioLife Solutions (BLFS) runs a 66.9% gross margin and a -16.7% operating margin, with a -68.7% net margin.
- Where do BioLife Solutions's ratios come from?
- Every ratio is computed from BioLife Solutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
